BaroNova late last week released the primary results from the pivotal ENDObesityII study of its TransPyloric Shuttle device intended to treat obesity. Results from the trial were presented at the Obesity Week 2018 conference’s scientific sessions, the San Carlos, Calif.-based company said. “Obesity is a worldwide epidemic with up to 40% of adult Americans suffering from […]
Wright Medical COO, ex-Tornier CEO Mowry, steps down | Personnel Moves May 5, 2016
Wright Medical COO, ex-Tornier CEO Mowry, steps down Wright Medical (NSDQ:WMGI) said yesterday its exec veep and chief operating officer, and former Tornier (NSDQ:TRNX) CEO, David Mowry will be stepping down from the company on May 6 to pursue other opportunities. The company did not indicate who would take Mowry’s position. Read more
The steady and successful climb of BaroNova
Welcome to the Medsiderplu interview, a special new feature at MassDevice, which will appear regularly. All interviews are conducted by Scott Nelson, Founder, Medsider. We hope you enjoy them. Henry Ford is famous for stating, “If I had asked people what they wanted, I would have built a faster horse.” Although it’s arguable whether he […]
BaroNova launches TPS weight-loss trial
BaroNova said today it enrolled the 1st 4 patients in its ENDObesity II study pivotal clinical trial to test its TransPyloric Shuttle designed to treat obesity. The TransPyloric Shuttle is inserted and removed through the mouth endoscopically to slow gastric emptying and encourage weight loss, the company said. In a feasibility study, patients with BMIs […]
Weight Loss: BaroNova nets $36.5m in Series D
Weight loss company BaroNova said it closed a $36.5 million Series D round of financing for its TransPyloric Shuttle endoscopically delivered and retrievable weight-loss device. The round was led by Delos Capital and Longitude Capital, and joined by existing investors Lumira Capital Partners, Onset ventures and Sante Ventures. “We are very excited about the opportunity to […]
Weight loss: Boston Scientific backs BaroNova in $27M funding round
Boston Scientific (NYSE:BSX) took part in a $27.3 million Series C round for weight loss device maker BaroNova, joined by Sante Ventures, Lumira Capital and a bevy of other venture capital shops.
MassDevice Network
@MassDevice
LinkedIn
YouTube